Login to Your Account

K-racking K-Ras

Insights, drug candidates for K-Ras-driven cancers

By Anette Breindl
Senior Science Editor

Friday, January 26, 2018

Separate research teams offered insight this week into how Ras-driven pancreatic cancers develop, and reported that a small molecule targeting mutated K-Ras led to tumor regression in patient-derived xenograft mouse models of K-Ras-driven cancers.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription